RELL2 and pancreatic ductal adenocarcinoma: RELL2 was previously shown to sensitize pancreatic ductal adenocarcinoma cells to the nucleoside analog gemcitabine [33], and the ability of RELTfms to sensitize cancer cells to chemotherapy is an avenue that needs further exploration.